Improving how people with glaucoma use eye drops
Quantifying and Understanding Glaucoma Eye Drop Medication Instillation and Adherence
This project looks at how older adults with glaucoma put in their eye drops and uses a motion-sensing system to help them take medication more reliably.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11293875 on NIH RePORTER |
What this research studies
If you have glaucoma and use eye drops, this project would track how you move when you try to put drops in your eyes using a small monitoring system called EAMS that records motion and time stamps. The system sends those recordings to your healthcare team so they can share clear feedback about your dosing and technique. The team has already used the system in lab tests to find movement patterns that predict whether drops actually make it into the eye, and now they want to see how people perform in everyday settings. The goal is to learn common problems and improve support so more patients get their medication into the eye correctly.
Who could benefit from this research
Good fit: Ideal candidates are adults, especially people aged 65 and older with a glaucoma diagnosis who use prescribed eye drop medications daily.
Not a fit: People who do not use eye drop medications for glaucoma or who are unwilling to have their drop-use monitored may not benefit from this project.
Why it matters
Potential benefit: If successful, this could help patients get their drops in more often and correctly, lowering the risk of vision loss from glaucoma.
How similar studies have performed: Previous lab-based work with the same motion-monitoring system has identified movement patterns that predict successful instillation, but testing in real-world home settings is more recent.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Newman-Casey, Paula Anne — University of Michigan at Ann Arbor
- Study coordinator: Newman-Casey, Paula Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.